S
Synlogic, Inc. (SYBX)
PNK – Real vaqt narxi. Valyuta: USD
0.64
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
PNK – Real vaqt narxi. Valyuta: USD
0.64
0.00 (0.00%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Synlogic, Inc., biotexnologiya kompaniyasi, Amerika Qo'shma Shtatlarida metabolik kasalliklarni davolash uchun sintetik biotiklarni kashf qilish va ishlab chiqish bilan shug'ullanadi. Uning quvur liniyasi fenilketonuriya davolash uchun SYNB1618; homosistinuriya davolash uchun I bosqichli klinik sinovlarda bo'lgan og'iz orqali yuboriladigan, tizimli ravishda so'rilmaydigan dori nomzodi SYNB1353; enterik giperoksaluriya davolash uchun og'iz orqali yuboriladigan, tizimli ravishda so'rilmaydigan dori nomzodi SYNB8802; va podagraning potentsial davolash uchun siydik kislotasini kamaytirish uchun SYNB2081ni o'z ichiga oladi. Kompaniya F. Hoffmann-La Roche Ltd va Hoffmann-La Roche Inc.; va Ginkgo Bioworks, Inc. bilan hamkorlik shartnomasiga ega. Synlogic, Inc. Vinsester, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James J. Collins Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Dr. Jose-Carlos Gutierrez-Ramos Ph.D. | Advisor |
| Dr. Timothy K. Lu M.D., Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Ms. Mary Beth Dooley | Principal Executive Officer & Principal Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 10-K/A | sybx-20251231.htm |
| 2026-03-12 | 10-K | sybx-20251231.htm |
| 2026-01-29 | 8-K/A | sybx-20260116.htm |
| 2026-01-20 | 8-K | sybx-20260116.htm |
| 2025-12-16 | 8-K | sybx-20251215.htm |
| 2025-11-26 | 8-K | sybx-20251121.htm |
| 2025-11-13 | 10-Q | sybx-20250930.htm |
| 2025-11-12 | ARS | sybx_12.31.2024_ars.pdf |
| 2025-08-18 | CORRESP | filename1.htm |
| 2025-08-15 | S-3/A | d89246ds3a.htm |